Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G ROSENBLUM

Showing results (81-90 of 243) with videos related to

Pageof 25
Sort By:
Archives of Pathology & Laboratory Medicine|September 3, 2002
Immunohistochemical confirmation of pulmonary papillary adenocarcinoma metastatic to ovariesJeanMarie Householder, Aaron Han, Mitchell I Edelson, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Tumor necrosis factor alpha and gamma-interferon enhancement of anti-epidermal growth factor receptor monoclonal antibody binding to human melanoma cellsK Mujoo, N J Donato, R Lapushin, et al.
Plos One|August 20, 2009
Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGelPål K Selbo, Michael G Rosenblum, Lawrence H Cheung, et al.
Molecular Biotherapy|December 1, 1990
Detection of cellular platinum using the monoclonal antibody 1C1K Nishikawa, R A Newman, L Murray, et al.
Molecular Biotherapy|March 1, 1991
A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin geloninM G Rosenblum, J L Murray, L Cheung, et al.
Molecular Cancer Therapeutics|July 17, 2013
The functionalized human serine protease granzyme B/VEGF₁₂₁ targets tumor vasculature and ablates tumor growthKhalid A Mohamedali, Yu Cao, Lawrence H Cheung, et al.
Cancer Treatment Reports|December 1, 1986
Phase I study of i.v. administered recombinant gamma interferon in cancer patientsR Kurzrock, J R Quesada, M G Rosenblum, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 19, 2014
Photochemical activation of the recombinant HER2-targeted fusion toxin MH3-B1/rGel; Impact of HER2 expression on treatment outcomeBente Bull-Hansen, Yu Cao, Kristian Berg, et al.
Gynecologic Oncology Reports|November 17, 2022
Surgical resection of a rare primary retroperitoneal mucinous borderline tumor of Müllerian Origin: A case reportTaylor R Kavanagh, Nneamaka Nwaoduah, Scott D Richard, et al.
Neoplasia (New York, N.Y.)|June 22, 2005
The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumorsSophia Ran, Khalid A Mohamedali, Troy A Luster, et al.
Pageof 25

Showing results (81-90 of 243) with videos related to

Sort By:
Pageof 25
Archives of Pathology & Laboratory Medicine|September 3, 2002
Immunohistochemical confirmation of pulmonary papillary adenocarcinoma metastatic to ovariesJeanMarie Householder, Aaron Han, Mitchell I Edelson, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Tumor necrosis factor alpha and gamma-interferon enhancement of anti-epidermal growth factor receptor monoclonal antibody binding to human melanoma cellsK Mujoo, N J Donato, R Lapushin, et al.
Plos One|August 20, 2009
Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGelPål K Selbo, Michael G Rosenblum, Lawrence H Cheung, et al.
Molecular Biotherapy|December 1, 1990
Detection of cellular platinum using the monoclonal antibody 1C1K Nishikawa, R A Newman, L Murray, et al.
Molecular Biotherapy|March 1, 1991
A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin geloninM G Rosenblum, J L Murray, L Cheung, et al.
Molecular Cancer Therapeutics|July 17, 2013
The functionalized human serine protease granzyme B/VEGF₁₂₁ targets tumor vasculature and ablates tumor growthKhalid A Mohamedali, Yu Cao, Lawrence H Cheung, et al.
Cancer Treatment Reports|December 1, 1986
Phase I study of i.v. administered recombinant gamma interferon in cancer patientsR Kurzrock, J R Quesada, M G Rosenblum, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 19, 2014
Photochemical activation of the recombinant HER2-targeted fusion toxin MH3-B1/rGel; Impact of HER2 expression on treatment outcomeBente Bull-Hansen, Yu Cao, Kristian Berg, et al.
Gynecologic Oncology Reports|November 17, 2022
Surgical resection of a rare primary retroperitoneal mucinous borderline tumor of Müllerian Origin: A case reportTaylor R Kavanagh, Nneamaka Nwaoduah, Scott D Richard, et al.
Neoplasia (New York, N.Y.)|June 22, 2005
The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumorsSophia Ran, Khalid A Mohamedali, Troy A Luster, et al.
Pageof 25